Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Desloratadine 5 mg tablets vs Aerius 5 mg tablets in healthy Thai volunteers (fasting)
TCTR20211015003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of desloratadine in allergic rhinitis (AR) and urticaria (2 arms), sponsored by Bio-innova. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
desloratadine
03
Conditions
allergic rhinitis (AR)urticaria
Beyond the preview
Go deeper on TCTR20211015003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211015003.